IMW 2019 | MRD positivity and associated reduction in MM PFS

Dr Jesus San Miguel

Jesus San Miguel, MD, of The Univeristy of Navarra Clinic, Pamplona, Spain, discusses the longer survival of measurable residual disease (MRD) negative patients compared to MRD positive, and the best methods for studying lesions. This interview was recorded at the International Myeloma Workshop, in Boston, MA.

Share this video  
Similar topics